{"license":"https://creativecommons.org/licenses/by/4.0/","dataset":"atlas","updatedThrough":"2026-08-15","guardrail":"The atlas exposes only relationships declared in the current public data. A link or issue grouping does not make unlike measures comparable, establish ownership or control, define an antitrust market, assign liability, or show that a policy event caused an economic outcome.","filters":{"depth":1,"edgeType":"all","edgeTypeMatched":true,"focus":"policy_entity:pent-express-scripts","focusMatched":true,"kind":"all","kindMatched":true,"layer":"all","layerMatched":true,"query":"","view":"network"},"summary":{"nodeCount":5478,"edgeCount":19193,"sourceCount":45,"profileCount":5433,"nodeKindCount":13,"layerCount":4,"eligibleEdgeCount":19193,"matchedNodeCount":4,"plottedEdgeCount":3,"plottedNodeCount":4,"hiddenNodeCount":0,"directNeighborCount":3},"focusNode":{"id":"policy_entity:pent-express-scripts","kind":"policy_entity","label":"Express Scripts, Inc.","shortLabel":"Express Scripts, Inc.","description":"Pharmacy benefit manager named in FTC study and administrative complaint records.","href":"/enforcement/entities/express-scripts-inc","metricLabel":"Named records","metricValue":"3","detail":"Official-record organization label","status":"record-only label","year":null,"color":"#ec4899","searchText":"express scripts, inc. pharmacy benefit manager named in ftc study and administrative complaint records. report_subject respondent remedy_subject","connectionCount":3},"nodes":[{"id":"policy_entity:pent-express-scripts","kind":"policy_entity","label":"Express Scripts, Inc.","shortLabel":"Express Scripts, Inc.","description":"Pharmacy benefit manager named in FTC study and administrative complaint records.","href":"/enforcement/entities/express-scripts-inc","metricLabel":"Named records","metricValue":"3","detail":"Official-record organization label","status":"record-only label","year":null,"color":"#ec4899","searchText":"express scripts, inc. pharmacy benefit manager named in ftc study and administrative complaint records. report_subject respondent remedy_subject","connectionCount":3,"distance":0,"labelVisible":true,"radius":20,"x":450,"y":260},{"id":"policy_record:evt-pbm-insulin-complaint-2024","kind":"policy_record","label":"FTC files administrative complaint against the three largest PBMs","shortLabel":"FTC files administrative...","description":"The FTC brought an administrative action alleging anticompetitive and unfair rebating and formulary practices involving Caremark, Express Scripts, OptumRx, and affiliated GPOs.","href":"/enforcement/records/pbm-insulin-complaint-2024","metricLabel":"Official stage","metricValue":"litigation","detail":"Federal Trade Commission / 2024-09-20","status":"complaint","year":2024,"color":"#f43f5e","searchText":"evt-pbm-insulin-complaint-2024 ftc files administrative complaint against the three largest pbms federal trade commission complaint litigation the ftc brought an administrative action alleging anticompetitive and unfair rebating and formulary practices involving caremark, express scripts, optumrx, and affiliated gpos. docket no. 9437","connectionCount":8,"x":450,"y":112,"distance":1,"radius":11,"labelVisible":true},{"id":"policy_record:evt-pbm-interim-report-2024","kind":"policy_record","label":"FTC releases interim staff report on prescription drug middlemen","shortLabel":"FTC releases interim sta...","description":"The FTC published interim findings on PBM concentration and vertical integration, including aggregate shares for the largest PBMs.","href":"/enforcement/records/pbm-interim-report-2024","metricLabel":"Official stage","metricValue":"monitoring","detail":"Federal Trade Commission / 2024-07-09","status":"report","year":2024,"color":"#f43f5e","searchText":"evt-pbm-interim-report-2024 ftc releases interim staff report on prescription drug middlemen federal trade commission report monitoring the ftc published interim findings on pbm concentration and vertical integration, including aggregate shares for the largest pbms.","connectionCount":8,"x":578.172,"y":334,"distance":1,"radius":11,"labelVisible":true},{"id":"policy_record:evt-pbm-express-scripts-settlement-2026","kind":"policy_record","label":"FTC announces proposed consent agreement with Express Scripts","shortLabel":"FTC announces proposed c...","description":"The FTC announced a proposed consent agreement with Express Scripts and affiliated entities addressing formulary design, patient cost sharing, manufacturer compensation, plan-sponsor transparency, community-pharmacy reimbursement, and related business practices.","href":"/enforcement/records/pbm-express-scripts-settlement-2026","metricLabel":"Official stage","metricValue":"remedy","detail":"Federal Trade Commission / 2026-02-04","status":"settlement","year":2026,"color":"#f43f5e","searchText":"evt-pbm-express-scripts-settlement-2026 ftc announces proposed consent agreement with express scripts federal trade commission settlement remedy the ftc announced a proposed consent agreement with express scripts and affiliated entities addressing formulary design, patient cost sharing, manufacturer compensation, plan-sponsor transparency, community-pharmacy reimbursement, and related business practices. docket no. 9437","connectionCount":4,"x":321.828,"y":334,"distance":1,"radius":11,"labelVisible":true}],"rows":[{"id":"named-in-record:peel-express-scripts-complaint","layer":"enforcement","relationshipType":"named_in_record","relationshipLabel":"respondent","fromId":"policy_record:evt-pbm-insulin-complaint-2024","fromKind":"policy_record","fromLabel":"FTC files administrative complaint against the three largest PBMs","fromHref":"/enforcement/records/pbm-insulin-complaint-2024","toId":"policy_entity:pent-express-scripts","toKind":"policy_entity","toLabel":"Express Scripts, Inc.","toHref":"/enforcement/entities/express-scripts-inc","evidenceLabel":"Exact official-record relationship","evidenceDetail":"The FTC administrative complaint names Express Scripts as a respondent.","sourceId":"ftc-pbm-insulin-complaint-2024","sourceUrl":"https://www.ftc.gov/news-events/news/press-releases/2024/09/ftc-sues-prescription-drug-middlemen-artificially-inflating-insulin-drug-prices","confidenceLevel":"bounded","indicatorId":null,"entityCode":null,"observationCount":null,"firstYear":null,"latestYear":null,"preferredView":null,"sourceIds":null,"guardrail":"A named-organization edge records the role encoded from one official record; it is not an independent liability or identity finding."},{"id":"named-in-record:peel-express-scripts-report","layer":"enforcement","relationshipType":"named_in_record","relationshipLabel":"report subject","fromId":"policy_record:evt-pbm-interim-report-2024","fromKind":"policy_record","fromLabel":"FTC releases interim staff report on prescription drug middlemen","fromHref":"/enforcement/records/pbm-interim-report-2024","toId":"policy_entity:pent-express-scripts","toKind":"policy_entity","toLabel":"Express Scripts, Inc.","toHref":"/enforcement/entities/express-scripts-inc","evidenceLabel":"Exact official-record relationship","evidenceDetail":"The FTC interim report identifies Express Scripts among the six PBMs that received Section 6(b) orders.","sourceId":"ftc-pbm-interim-2024","sourceUrl":"https://www.ftc.gov/news-events/news/press-releases/2024/07/ftc-releases-interim-staff-report-prescription-drug-middlemen","confidenceLevel":"bounded","indicatorId":null,"entityCode":null,"observationCount":null,"firstYear":null,"latestYear":null,"preferredView":null,"sourceIds":null,"guardrail":"A named-organization edge records the role encoded from one official record; it is not an independent liability or identity finding."},{"id":"named-in-record:peel-express-scripts-settlement","layer":"enforcement","relationshipType":"named_in_record","relationshipLabel":"remedy subject","fromId":"policy_record:evt-pbm-express-scripts-settlement-2026","fromKind":"policy_record","fromLabel":"FTC announces proposed consent agreement with Express Scripts","fromHref":"/enforcement/records/pbm-express-scripts-settlement-2026","toId":"policy_entity:pent-express-scripts","toKind":"policy_entity","toLabel":"Express Scripts, Inc.","toHref":"/enforcement/entities/express-scripts-inc","evidenceLabel":"Exact official-record relationship","evidenceDetail":"The FTC settlement announcement identifies Express Scripts among the entities subject to the proposed consent agreement.","sourceId":"ftc-express-scripts-settlement-2026","sourceUrl":"https://www.ftc.gov/news-events/news/press-releases/2026/02/ftc-secures-landmark-settlement-express-scripts-lower-drug-costs-american-patients","confidenceLevel":"bounded","indicatorId":null,"entityCode":null,"observationCount":null,"firstYear":null,"latestYear":null,"preferredView":null,"sourceIds":null,"guardrail":"A named-organization edge records the role encoded from one official record; it is not an independent liability or identity finding."}]}